News

Burn injury risk doubles in HOT patients who smoke


 

AT CHEST 2014

References

Although nearly three-quarters of the 55-member cohort had less than a 5% total body surface–area burn, Dr. Baker said that in a patient population with baseline respiratory compromise and respiratory failure, this was an alarming rate of morbidity, particularly since half of the injured were intubated, and bronchonscopic exam revealed a third of these patients also had inhalation injuries.

“And here’s the kicker,” said Dr. Baker. “Eight deaths over 5 years. This is huge. So when these [individuals] get burned, it’s often really bad. Several of them had house fires, and we were able to find in the chart where other people [in the home] were burned and admitted to the hospital.”

Still, after a median 5-day stay, almost all the patients who survived were discharged with prescriptions for HOT, including the so-called “repeat offenders.” Because nearly half of all surviving smoking-related HOT patients were discharged to a higher level of care, this cohort tended to have higher health care utilization rates as well, Dr. Baker noted.

A surprise finding was that more than a quarter of the cohort had either current or concomitant problems with substance abuse. “We were not expecting that, and it has not been previously reported,” Dr. Baker said.

The data demonstrate a need for the screening of HOT patients as to whether they smoke and whether they have substance use issues, she said. If either condition applies, then faster follow-up and, potentially, counseling could be offered, including better education about the risks of oxygen therapy. “Currently, we have no formalized way to educate patients on the dangers of those tanks in the home,” said Dr. Baker.

The data raise questions about the risk-benefit ratio of prescribing any breathing aid to COPD patients who are also smokers.

“I don’t know how much sense it makes to keep throwing these inhalers, which cost hundreds of dollars a month, at people who continue to smoke,” Dr. Baker said in an interview. “We take all comers, and we think oxygen therapy helps, and prolongs life, but when you factor in smoking, we don’t really know what the risks and benefits are.”

A large study population would be needed to determine the risks and benefits, she added.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Pages

Recommended Reading

FVC inadequate when assessing scleroderma lung disease
MDedge Dermatology
Stem-cell transplants growing routine for severe scleroderma
MDedge Dermatology
OTC topical acne meds can cause severe reactions
MDedge Dermatology
No blood clot risk found with HPV vaccination
MDedge Dermatology
No blood clot risk found with HPV vaccination
MDedge Dermatology
FDA approves C1-esterase inhibitor for hereditary angioedema
MDedge Dermatology
Texting intervention helped smokers quit
MDedge Dermatology
VIDEO: Experts offer top tips for flu season 2014-2015
MDedge Dermatology
Novel oral prophylaxis tames hereditary angioedema
MDedge Dermatology
CDC predicts bad flu season, stresses vaccination, antiviral treatment
MDedge Dermatology